Company Profile
Profile: Hande Pharma Limited specializes in research, development of active pharmaceutical ingredients, intermediates and plant extracts. Our product line includes ethyl (3R,S)-2,2-difluoro-3-hydroxy-3-(2,2-dimethyldioxolan-4-yl)propionate, 2-deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate, 2',2'-difluoro-2'-deoxycytidine-3',5'-dibenzoate, gemcitabine base, ethyl bromodifluoroacetate, adefovir dipivoxil, entecavir, intermediates of capecitabine, 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl), 4-(4-fluorobenzoyl)butyric acid, ezetimibe, faropenem, ertapenem and meropenem.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1,3,5-Tri-O-acetyl-2-deoxy-α-D-erythro-pentofuranose |
96291-74-6 | Inquiry | ||
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate |
Cytidine,2′-deoxy-2′,2′-difluoro-,3′,5′-dibenzoate;3′,5′-Di-O-benzoyl-2′-deoxy-2′,2′-difluorocytidine |
134790-39-9 | Inquiry | |
darifenacin |
3-Pyrrolidineacetamide,1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-,(3S)-;3-Pyrrolidineacetamide,1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-,(S)-;(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide;Darifenacin;(S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide;UK 88525;(3S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-1-pyrrolidine;(S)-3-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine;(S)-(-)-3-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine;(S)-2-[1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide;(3S)-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine;Vesigard;2-[(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide |
133099-04-4 | Inquiry |
CONTACT INFORMATION
Sign In for Details